{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:42:20Z","timestamp":1791308540821,"version":"4.3.1"},"reference-count":21,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T00:00:00Z","timestamp":1666828800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Newborn Screening and Genetics Resource Center"},{"name":"The Legacy of Angels Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJNS"],"abstract":"<jats:p>Testing immunoreactive trypsinogen (IRT) is the first step in cystic fibrosis (CF) newborn screening. While high IRT is associated with CF, some cases are missed. This survey aimed to find factors associated with missed CF cases due to IRT levels below program cutoffs. Twenty-nine states responded to a U.S-wide survey and 13 supplied program-related data for low IRT false screen negative cases (CFFN) and CF true screen positive cases (CFTP) for analysis. Rates of missed CF cases and odds ratios were derived for each factor in CFFNs, and two CFFN subgroups, IRT above (\u201chigh\u201d) and below (\u201clow\u201d) the CFFN median (39 ng\/mL) compared to CFTPs for this entire sample set. Factors associated with \u201chigh\u201d CFFN subgroup were Black race, higher IRT cutoff, fixed IRT cutoff, genotypes without two known CF-causing variants, and meconium ileus. Factors associated with \u201clow\u201d CFFN subgroup were older age at specimen collection, Saturday birth, hotter season of newborn dried blood spot collection, maximum \u2265 3 days laboratories could be closed, preterm birth, and formula feeding newborns. Lowering IRT cutoffs may reduce \u201chigh\u201d IRT CFFNs. Addressing hospital and laboratory factors (like training staff in collection of blood spots, using insulated containers during transport and reducing consecutive days screening laboratories are closed) may reduce \u201clow\u201d IRT CFFNs.<\/jats:p>","DOI":"10.3390\/ijns8040058","type":"journal-article","created":{"date-parts":[[2022,10,27]],"date-time":"2022-10-27T20:37:58Z","timestamp":1666903078000},"page":"58","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Missed Cystic Fibrosis Newborn Screening Cases due to Immunoreactive Trypsinogen Levels below Program Cutoffs: A National Survey of Risk Factors"],"prefix":"10.3390","volume":"8","author":[{"given":"Martin","family":"Kharrazi","sequence":"first","affiliation":[{"name":"California Department of Public Health, Richmond, CA 94804, USA"},{"name":"Sequoia Foundation, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlene","family":"Sacramento","sequence":"additional","affiliation":[{"name":"Sequoia Foundation, La Jolla, CA 92037, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Comeau","sequence":"additional","affiliation":[{"name":"New England Newborn Screening Program, UMass Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Hale","sequence":"additional","affiliation":[{"name":"New England Newborn Screening Program, UMass Chan Medical School, Worcester, MA 01605, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Caggana","sequence":"additional","affiliation":[{"name":"New York State Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9928-2698","authenticated-orcid":false,"given":"Denise","family":"Kay","sequence":"additional","affiliation":[{"name":"New York State Newborn Screening Program, Wadsworth Center, New York State Department of Health, Albany, NY 12208, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Lee","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, Austin, TX 78756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Reilly","sequence":"additional","affiliation":[{"name":"Texas Department of State Health Services, Austin, TX 78756, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2508-1276","authenticated-orcid":false,"given":"John","family":"Thompson","sequence":"additional","affiliation":[{"name":"Washington State Department of Health, Public Health Laboratories, Newborn Screening Program, Shoreline, WA 98155, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4124-316X","authenticated-orcid":false,"given":"Samya","family":"Nasr","sequence":"additional","affiliation":[{"name":"Michigan Medicine, University of Michigan, Ann Arbor, MI 48109, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kleyn","sequence":"additional","affiliation":[{"name":"Michigan Department of Health and Human Services, Lansing, MI 48913, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Hoffman","sequence":"additional","affiliation":[{"name":"Wisconsin Newborn Screening Laboratory at Wisconsin State Laboratory of Hygiene, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8707-1834","authenticated-orcid":false,"given":"Mei","family":"Baker","sequence":"additional","affiliation":[{"name":"Wisconsin Newborn Screening Laboratory at Wisconsin State Laboratory of Hygiene, University of Wisconsin School of Medicine and Public Health, Madison, WI 53706, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen","family":"Clarke","sequence":"additional","affiliation":[{"name":"Louisiana Office of Public Health, Baton Rouge, LA 70802, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Harris","sequence":"additional","affiliation":[{"name":"Louisiana Office of Public Health, Baton Rouge, LA 70802, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-8521","authenticated-orcid":false,"given":"M.","family":"Dorley","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Newborn Screening Laboratory and Follow-Up Program, Nashville, TN 37216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hilary","family":"Fryman","sequence":"additional","affiliation":[{"name":"Tennessee Department of Health, Newborn Screening Laboratory and Follow-Up Program, Nashville, TN 37216, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankit","family":"Sutaria","sequence":"additional","affiliation":[{"name":"Georgia Department of Public Health, Atlanta, GA 30303, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Hietala","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, Public Health Laboratory, Newborn Screening, St. Paul, MN 55164, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Winslow","sequence":"additional","affiliation":[{"name":"Minnesota Department of Health, Public Health Laboratory, Newborn Screening, St. Paul, MN 55164, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Richards","sequence":"additional","affiliation":[{"name":"Maine Newborn Screening Program, Augusta, ME 04333, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6272-7350","authenticated-orcid":false,"given":"Bradford","family":"Therrell","sequence":"additional","affiliation":[{"name":"National Newborn Screening and Global Resource Center, Austin, TX 78759, USA"},{"name":"Department of Pediatrics, The University of Texas Health Science Center at San Antonio, San Antonio, TX 78249, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2022,10,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1542\/peds.2006-1498","article-title":"Cystic fibrosis diagnosed after 2 months of age leads to worse outcomes and requires more therapy","volume":"119","author":"Sims","year":"2007","journal-title":"Pediatrics"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"S83","DOI":"10.1016\/j.jpeds.2005.08.005","article-title":"Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: Screening efficacy and diagnostic outcomes","volume":"147","author":"Sontag","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1016\/j.jpeds.2005.08.004","article-title":"Newborn screening for cystic fibrosis in Wisconsin: Nine-year experience with routine trypsinogen\/DNA testing","volume":"147","author":"Rock","year":"2005","journal-title":"J. Pediatr."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1542\/peds.113.6.1573","article-title":"Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: A cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections","volume":"113","author":"Comeau","year":"2004","journal-title":"Pediatrics"},{"key":"ref_5","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2019). Newborn Screening for Cystic Fibrosis, Clinical and Laboratory Standards Institute. [2nd ed.]. CLSI Guideline NBS05."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.jpeds.2006.07.026","article-title":"Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening","volume":"149","author":"Sontag","year":"2006","journal-title":"J. Pediatr."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ymgme.2012.02.013","article-title":"Immunoreactive Trypsinogen (IRT) as a Biomarker for Cystic Fibrosis: Challenges in newborn dried blood spot screening","volume":"106","author":"Therrell","year":"2012","journal-title":"Mol. Genet. Metab."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1002\/ppul.21509","article-title":"Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening","volume":"46","author":"Rock","year":"2011","journal-title":"Pediatr. Pulmonol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e338","DOI":"10.1542\/peds.2008-1681","article-title":"Clarification of laboratory and clinical variables that influence cystic fibrosis newborn screening with initial analysis of immunoreactive trypsinogen","volume":"123","author":"Kloosterboer","year":"2009","journal-title":"Pediatrics"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/archdischild-2012-301968","article-title":"Thirty-years of screening for cystic fibrosis in East Anglia","volume":"97","author":"Calvin","year":"2012","journal-title":"Arch. Dis. Child"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Taccetti, G., Botti, M., Terlizzi, V., Cavicchi, M.C., Neri, A.S., Galici, V., Mergni, G., Centrone, C., Peroni, D.G., and Festini, F. (2020). Clinical and genotypical features of false-negative patients in 26 years of cystic fibrosis neonatal screening in Tuscany, Italy. Diagnostics, 10.","DOI":"10.3390\/diagnostics10070446"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1542\/peds.85.6.1001","article-title":"Newborn screening for cystic fibrosis is complicated by age-related decline in immunoreactive trypsinogen levels","volume":"85","author":"Rock","year":"1990","journal-title":"Pediatrics"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1542\/peds.99.6.819","article-title":"Newborn screening for cystic fibrosis in Wisconsin: Comparison of biochemical and molecular methods","volume":"99","author":"Gregg","year":"1997","journal-title":"Pediatrics"},{"key":"ref_14","unstructured":"Eaton, R.B. Personal Communication."},{"key":"ref_15","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2013). Blood Collection on Filter Paper for Newborn Screening Programs; Approved Standard\u2014Sixth Edition, Clinical and Laboratory Standards Institute. CLSI Document NBS01-A6."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.jcf.2006.05.008","article-title":"A survey of newborn screening for cystic fibrosis in Europe","volume":"6","author":"Southern","year":"2007","journal-title":"J. Cyst. Fibros."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/archdischild-2020-318999","article-title":"Cystic fibrosis newborn screening: The importance of bloodspot sample quality","volume":"106","author":"Doull","year":"2021","journal-title":"Arch. Dis. Child"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/8904_2011_55","article-title":"Cystic fibrosis newborn screening: Distribution of blood immunoreactive trypsinogen concentrations in hypertrypsinemic neonates","volume":"4","author":"Paracchini","year":"2012","journal-title":"JIMD Rep."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.clinbiochem.2014.12.009","article-title":"Galactose-1-phosphate uridyltransferase dried blood spot quality control materials for newborn screening tests","volume":"48","author":"Adam","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.clinbiochem.2011.09.010","article-title":"The stability of markers in dried-blood spots for recommended newborn screening disorders in the United States","volume":"44","author":"Adam","year":"2011","journal-title":"Clin. Biochem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.jpeds.2008.05.005","article-title":"Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report","volume":"153","author":"Farrell","year":"2008","journal-title":"J. Pediatr."}],"container-title":["International Journal of Neonatal Screening"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2409-515X\/8\/4\/58\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:04:16Z","timestamp":1760144656000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2409-515X\/8\/4\/58"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,27]]},"references-count":21,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["ijns8040058"],"URL":"https:\/\/doi.org\/10.3390\/ijns8040058","relation":{},"ISSN":["2409-515X"],"issn-type":[{"value":"2409-515X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,27]]}}}